476 related articles for article (PubMed ID: 17212694)
1. Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity.
Hartmann J; Kiewert C; Duysen EG; Lockridge O; Greig NH; Klein J
J Neurochem; 2007 Mar; 100(5):1421-9. PubMed ID: 17212694
[TBL] [Abstract][Full Text] [Related]
2. Choline availability and acetylcholine synthesis in the hippocampus of acetylcholinesterase-deficient mice.
Hartmann J; Kiewert C; Duysen EG; Lockridge O; Klein J
Neurochem Int; 2008 May; 52(6):972-8. PubMed ID: 18023504
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
4. Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice.
Girard E; Bernard V; Minic J; Chatonnet A; Krejci E; Molgó J
Life Sci; 2007 May; 80(24-25):2380-5. PubMed ID: 17467011
[TBL] [Abstract][Full Text] [Related]
5. Reduced acetylcholine receptor density, morphological remodeling, and butyrylcholinesterase activity can sustain muscle function in acetylcholinesterase knockout mice.
Adler M; Manley HA; Purcell AL; Deshpande SS; Hamilton TA; Kan RK; Oyler G; Lockridge O; Duysen EG; Sheridan RE
Muscle Nerve; 2004 Sep; 30(3):317-27. PubMed ID: 15318343
[TBL] [Abstract][Full Text] [Related]
6. Effects of acetylcholinesterase and butyrylcholinesterase inhibition on breathing in mice adapted or not to reduced acetylcholinesterase.
Boudinot E; Taysse L; Daulon S; Chatonnet A; Champagnat J; Foutz AS
Pharmacol Biochem Behav; 2005 Jan; 80(1):53-61. PubMed ID: 15652380
[TBL] [Abstract][Full Text] [Related]
7. Effects of rivastigmine and donepezil on brain acetylcholine levels in acetylcholinesterase-deficient mice.
Naik RS; Hartmann J; Kiewert C; Duysen EG; Lockridge O; Klein J
J Pharm Pharm Sci; 2009; 12(1):79-85. PubMed ID: 19470293
[TBL] [Abstract][Full Text] [Related]
8. Mice heterozygous for AChE are more sensitive to AChE inhibitors but do not respond to BuChE inhibition.
Mohr F; Zimmermann M; Klein J
Neuropharmacology; 2013 Apr; 67():37-45. PubMed ID: 23147415
[TBL] [Abstract][Full Text] [Related]
9. Altered hippocampal muscarinic receptors in acetylcholinesterase-deficient mice.
Volpicelli-Daley LA; Duysen EG; Lockridge O; Levey AI
Ann Neurol; 2003 Jun; 53(6):788-96. PubMed ID: 12783426
[TBL] [Abstract][Full Text] [Related]
10. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
Pacheco G; Palacios-Esquivel R; Moss DE
J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
[TBL] [Abstract][Full Text] [Related]
11. Modeling effects of oxyanion hole on the ester hydrolysis catalyzed by human cholinesterases.
Gao D; Zhan CG
J Phys Chem B; 2005 Dec; 109(48):23070-6. PubMed ID: 16854005
[TBL] [Abstract][Full Text] [Related]
12. Developmental lead neurotoxicity: alterations in brain cholinergic system.
Reddy GR; Devi BC; Chetty CS
Neurotoxicology; 2007 Mar; 28(2):402-7. PubMed ID: 16678265
[TBL] [Abstract][Full Text] [Related]
13. Dysfunctional Presynaptic M2 Receptors in the Presence of Chronically High Acetylcholine Levels: Data from the PRiMA Knockout Mouse.
Mohr F; Krejci E; Zimmermann M; Klein J
PLoS One; 2015; 10(10):e0141136. PubMed ID: 26506622
[TBL] [Abstract][Full Text] [Related]
14. Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout mice.
Volpicelli-Daley LA; Hrabovska A; Duysen EG; Ferguson SM; Blakely RD; Lockridge O; Levey AI
Mol Pharmacol; 2003 Dec; 64(6):1309-16. PubMed ID: 14645660
[TBL] [Abstract][Full Text] [Related]
15. Transgenic inactivation of acetylcholinesterase impairs homeostasis in mouse hippocampal granule cells.
Cohen JE; Zimmerman G; Melamed-Book N; Friedman A; Dori A; Soreq H
Hippocampus; 2008; 18(2):182-92. PubMed ID: 17960645
[TBL] [Abstract][Full Text] [Related]
16. Effect of distigmine bromide on the central cholinergic system.
Nakayama K; Katsu H; Kitazumi K
J Psychopharmacol; 2009 Mar; 23(2):190-3. PubMed ID: 18515453
[TBL] [Abstract][Full Text] [Related]
17. Protection from the toxicity of diisopropylfluorophosphate by adeno-associated virus expressing acetylcholinesterase.
Li B; Duysen EG; Poluektova LY; Murrin LC; Lockridge O
Toxicol Appl Pharmacol; 2006 Jul; 214(2):152-65. PubMed ID: 16443250
[TBL] [Abstract][Full Text] [Related]
18. Are there non-catalytic functions of acetylcholinesterases? Lessons from mutant animal models.
Cousin X; Strähle U; Chatonnet A
Bioessays; 2005 Feb; 27(2):189-200. PubMed ID: 15666354
[TBL] [Abstract][Full Text] [Related]
19. Synaptic remodeling at the skeletal neuromuscular junction of acetylcholinesterase knockout mice and its physiological relevance.
Girard E; Barbier J; Chatonnet A; Krejci E; Molgó J
Chem Biol Interact; 2005 Dec; 157-158():87-96. PubMed ID: 16274683
[TBL] [Abstract][Full Text] [Related]
20. Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain.
Mesulam M; Guillozet A; Shaw P; Quinn B
Neurobiol Dis; 2002 Feb; 9(1):88-93. PubMed ID: 11848688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
